Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. Februar 2014 09:06 ET | Quelle: Enzymotec Ltd.

Enzymotec Ltd. Announces it has Been Granted Patents for INFAT(R)'s Uses in Canada and the US

MIGDAL HA'EMEQ, Israel, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that it was...
13. Januar 2014 09:00 ET | Quelle: Enzymotec Ltd.

Enzymotec Ltd. Announces Completion of Its Migdal Ha'Emeq Manufacturing Facility Expansion

MIGDAL HA'EMEQ, Israel, Jan. 13, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced the...
07. Januar 2014 16:05 ET | Quelle: Enzymotec Ltd.

Enzymotec Ltd. Announces "New Food Raw Material" Certification for K-REAL(R) Krill Oil in China

MIGDAL HA'EMEQ, Israel, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today its...
06. Januar 2014 16:05 ET | Quelle: Enzymotec Ltd.

Enzymotec Ltd. to Participate in the 16th Annual ICR XChange Conference

MIGDAL HA'EMEQ, Israel, Jan. 6, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced...
06. Januar 2014 08:00 ET | Quelle: Enzymotec Ltd.

Enzymotec Ltd. Granted Patent for a Lipid Preparation Use Method

MIGDAL HA'EMEQ, Israel, Jan. 6, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that it...
02. Januar 2014 08:00 ET | Quelle: Enzymotec Ltd.

Enzymotec Ltd. Announces Changes to Its Board of Directors

MIGDAL HA'EMEQ, Israel, Jan. 2, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that it...
18. Dezember 2013 08:01 ET | Quelle: Enzymotec Ltd.

Enzymotec Ltd. Announces Signing of Settlement Term Sheet

MIGDAL HA'EMEQ, Israel, Dec. 18, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced...
09. Dezember 2013 08:00 ET | Quelle: Enzymotec Ltd.

Enzymotec Ltd. Announces Publication Acceptance of Clinical Study Results on Usage of Vayacog(R) in Non-Demented Elderly

MIGDAL HA'EMEQ, Israel, Dec. 9, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today the...
04. Dezember 2013 08:00 ET | Quelle: Enzymotec Ltd.

Enzymotec Ltd. and Polar Omega A/S Sign a Joint Venture Agreement

MIGDAL HA'EMEQ, Israel and ESBJERG, Denmark, Dec. 4, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, and...
03. Dezember 2013 08:00 ET | Quelle: Enzymotec Ltd.

Enzymotec Ltd. Announces Publication Acceptance of Clinical Study Results on K-REAL(TM) Usage Health Benefits

MIGDAL HA'EMEQ, Israel, Dec. 3, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today the acceptance...

Vorherige Seite

Nächste Seite